FDA 483 - Patrick Clarke, M.D. - May 01, 2021

Patrick Clarke, M.D. in Los Angeles, CA, was inspected from April 26 to May 1, 2021, as a clinical investigator. The inspection revealed significant deficiencies in conducting a clinical study, including failures to report adverse events and numerous protocol deviations. These issues indicate a lack of adherence to the investigational plan and signed statement of investigator.